Trials / Unknown
UnknownNCT04958187
Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects
An Open Label, Single-Dose Study to Evaluate the Safety and Pharmacokinetics of ANG-3777 Injected Intravenously in Stable Adult Maintenance Hemodialysis Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (estimated)
- Sponsor
- Angion Biomedica Corp · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the pharmacokinetics and safety of a single-dose of ANG-3777 in subjects with renal failure receiving maintenance hemodialysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ANG-3777 | Arm assigned to this intervention will receive 2 mg/kg, IV |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2021-10-01
- Completion
- 2021-10-01
- First posted
- 2021-07-12
- Last updated
- 2021-07-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04958187. Inclusion in this directory is not an endorsement.